ABOT news and notes Abbott Laboratories (Pakistan) Limited
Abbott Laboratories (Pakistan) Limited (ABOT) news and notes: the SuperX note and what changed (4 items). The note is written by SuperX’s AI from its own figures. What changed is listed newest first.
What SuperX wrote about ABOT
On 5 Nov the price rose 3.18%. The pharmaceuticals sector median rose 2.6%, so the sector moved too.
Last year the company filed its annual results on 16 Mar. The period ends 31 Dec.
The company filed nine-month results on 27 Oct. Earnings per share rose 39.58% from the year-ago period.
Written by SuperX’s analyst desk from SuperX’s own figures, from the close of 13 Nov 2026. Each number was checked against those figures. Not advice.
What changed for ABOT, newest first
- 13 Nov 2026Closed 1,000.00, +0.52%. Volume 3,473, 0.3 times the average of the 30 sessions before it, 13,568.
- 2 Nov 2026Trend read changed to leaning up: above the 50-day average; up 7.4% over 1 month.
- 27 Oct 2026Quarter ended 30 Sep 2026: earnings per share Rs 25.99, sales Rs 20.6 bn, up 39.6% on the same quarter a year before.
- NextAnnual results (to 31 Dec 2026) expected 2 Feb 2027 – 16 Mar 2027, a projection. An estimate from the dates of the last 6 filings.
As of the close of 13 Nov 2026. Closes and notices: PSX. Trend read: SuperX, from daily closes. Volume: against the average of the 30 sessions before the last. Next results: an estimate from the dates of the last 6 filings. Not advice.
More on ABOT
- ABOT share price and overview
- ABOT dividend history
- Pharmaceuticals sector
- AGP news and notes · AGP Limited
- CPHL news and notes · Citi Pharma Ltd.
- HALEON news and notes · Haleon Pakistan Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .